Literature DB >> 23918301

Association between an insertion/deletion polymorphism within 3'UTR of SGSM3 and risk of hepatocellular carcinoma.

Chaoqun Wang1, Hua Zhao, Xiankun Zhao, Jiao Wan, Dayong Wang, Wanli Bi, Xinghong Jiang, Yuzhen Gao.   

Abstract

Hepatocellular carcinoma (HCC) is the most common primary hepatic malignancy, and multiple host genetic factors are believed to contribute to HCC development. The small G protein signaling modulator 3 (SGSM3) has been shown to be associated with small G protein coupled receptor signal transduction pathway, suggesting a potential role in HCC susceptibility. We carried out a case-control study in a Chinese population (502 cases and 513 controls) to determine whether the 4-bp insertion/deletion polymorphism (rs56228771) in 3' untranslated region of SGSM3 could affect HCC susceptibility. Logistic regression analysis showed that compared with the del/del genotype, the ins/del genotype of rs56228771 was associated with a significantly decreased risk of HCC [adjusted odd ratio = 0.55, 95% confidence interval (CI) = 0.42-0.73, P = 1.93 × 10(-5)]. The combined ins/del + ins/ins genotypes contributed to a 45% decreased HCC risk (95% CI = 0.42-0.73, P = 1.03 × 10(-5)). This protective trend was more prominent in the HBsAg-negative subgroup. Furthermore, in vivo experiments showed that mRNA levels of SGSM3 from HCC tumor tissues and adjacent non-HCC tissues were correlated with rs56228771 genotypes. Tissue samples with ins/ins genotype have the highest level of SGSM3, which are 2.85-3.00-fold and 1.46-1.57-fold higher than that with ins/del and del/del genotype, respectively. Similar results were also observed with four common hepatoma cell lines in vitro. In addition, compared with HCC tissues, significantly higher SGSM3 expression was observed in adjacent non-HCC tissues (fold change = 2.48), implying its tumor suppressor roles in HCC. Bioinformatics prediction showed that the insertion allele disrupted a binding site for microRNA (miRNA)-151-5p, which would upregulate SGSM3. Taken together, we provided initial evidence that rs56228771 may contribute to hepatocarcinogenesis, possibly by affecting SGSM3 expression through a miRNA-mediated regulation. The replication of our studies in other populations and functional analysis will further strengthen the underlining mechanism.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23918301     DOI: 10.1007/s13277-013-1039-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  26 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Risk of HCC: genetic heterogeneity and complex genetics.

Authors:  Tommaso A Dragani
Journal:  J Hepatol       Date:  2009-11-24       Impact factor: 25.083

Review 3.  Hepatocellular carcinoma: A global view.

Authors:  Ju Dong Yang; Lewis R Roberts
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-07-13       Impact factor: 46.802

4.  Polymerase chain reaction amplification products separated on rehydratable polyacrylamide gels and stained with silver.

Authors:  R C Allen; G Graves; B Budowle
Journal:  Biotechniques       Date:  1989 Jul-Aug       Impact factor: 1.993

Review 5.  The epidemiology and prevention of hepatocellular carcinoma.

Authors:  A Monto; T L Wright
Journal:  Semin Oncol       Date:  2001-10       Impact factor: 4.929

Review 6.  The global epidemiology of hepatocellular carcinoma: present and future.

Authors:  Katherine A McGlynn; W Thomas London
Journal:  Clin Liver Dis       Date:  2011-05       Impact factor: 6.126

7.  Transcriptional regulation of the TATA-binding protein by Ras cellular signaling.

Authors:  S A Johnson; N Mandavia; H D Wang; D L Johnson
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

Review 8.  Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection.

Authors:  Shu-Chun Chuang; Carlo La Vecchia; Paolo Boffetta
Journal:  Cancer Lett       Date:  2008-12-16       Impact factor: 8.679

9.  Identification of three novel proteins (SGSM1, 2, 3) which modulate small G protein (RAP and RAB)-mediated signaling pathway.

Authors:  Hao Yang; Takashi Sasaki; Shinsei Minoshima; Nobuyoshi Shimizu
Journal:  Genomics       Date:  2007-05-23       Impact factor: 5.736

10.  Insertion/deletion polymorphisms in the promoter region of BRM contribute to risk of hepatocellular carcinoma in Chinese populations.

Authors:  Xueren Gao; Moli Huang; Limin Liu; Yan He; Qiang Yu; Hua Zhao; Chunxiao Zhou; Jinkun Zhang; Zhansheng Zhu; Jiao Wan; Xinghong Jiang; Yuzhen Gao
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

View more
  12 in total

1.  An indel polymorphism in the 3' untranslated region of JAK1 confers risk for hepatocellular carcinoma possibly by regulating JAK1 transcriptional activity in a Chinese population.

Authors:  Qiang Yu; Weifeng Qian; Jian Wang; Yejiao Wu; Jinkun Zhang; Weichang Chen
Journal:  Oncol Lett       Date:  2018-03-26       Impact factor: 2.967

2.  Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma.

Authors:  Moqin Qiu; Yingchun Liu; Xiangyuan Yu; Linyuan Qin; Chunhua Bei; Xiaoyun Zeng; Xiaoqiang Qiu; Bo Tang; Songqing He; Hongping Yu
Journal:  Tumour Biol       Date:  2015-10-17

3.  PTK6 promotes hepatocellular carcinoma cell proliferation and invasion.

Authors:  Xiaohong Chen; Bo Song; Yuanlong Lin; Lijun Cao; Shiyan Feng; Lin Zhang; Fuxiang Wang
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

4.  A functional variant at miRNA-122 binding site in IL-1α 3' UTR predicts risk and HPV-positive tumours of oropharyngeal cancer.

Authors:  Yang Zhang; Erich M Sturgis; Yan Sun; Chuanzheng Sun; Qingyi Wei; Zhigang Huang; Guojun Li
Journal:  Eur J Cancer       Date:  2015-05-14       Impact factor: 9.162

Review 5.  MicroRNA binding site polymorphisms as biomarkers in cancer management and research.

Authors:  Monica Cipollini; Stefano Landi; Federica Gemignani
Journal:  Pharmgenomics Pers Med       Date:  2014-07-23

Review 6.  Dysregulated MicroRNA Expression Profiles and Potential Cellular, Circulating and Polymorphic Biomarkers in Non-Hodgkin Lymphoma.

Authors:  Gabrielle Bradshaw; Heidi G Sutherland; Larisa M Haupt; Lyn R Griffiths
Journal:  Genes (Basel)       Date:  2016-12-17       Impact factor: 4.096

7.  Association of insertion-deletions polymorphisms with colorectal cancer risk and clinical features.

Authors:  Diego Marques; Layse Raynara Ferreira-Costa; Lorenna Larissa Ferreira-Costa; Romualdo da Silva Correa; Aline Maciel Pinheiro Borges; Fernanda Ribeiro Ito; Carlos Cesar de Oliveira Ramos; Raul Hernandes Bortolin; André Ducati Luchessi; Ândrea Ribeiro-Dos-Santos; Sidney Santos; Vivian Nogueira Silbiger
Journal:  World J Gastroenterol       Date:  2017-10-07       Impact factor: 5.742

8.  The Modifying Effect of a Functional Variant at the miRNA Binding Site in E2F1 Gene on Recurrence of Oropharyngeal Cancer Patients with Definitive Radiotherapy.

Authors:  Hua Zhang; Erich Sturgis; Lijun Zhu; Zhongming Lu; Ye Tao; Hongliang Zheng; Guojun Li
Journal:  Transl Oncol       Date:  2018-03-22       Impact factor: 4.243

9.  A functional variant at miRNA-122 binding site in IL-1a 3' UTR predicts risk of recurrence in patients with oropharyngeal cancer.

Authors:  Chengyuan Wang; Erich M Sturgis; Xingming Chen; Qingyi Wei; Guojun Li
Journal:  Oncotarget       Date:  2016-06-07

10.  Transcriptional signature of lymphoblastoid cell lines of BRCA1, BRCA2 and non-BRCA1/2 high risk breast cancer families.

Authors:  Marie-Christine Pouliot; Charu Kothari; Charles Joly-Beauparlant; Yvan Labrie; Geneviève Ouellette; Jacques Simard; Arnaud Droit; Francine Durocher
Journal:  Oncotarget       Date:  2017-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.